Compare ENTX & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTX | FOFO |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 85.2M |
| IPO Year | 2015 | N/A |
| Metric | ENTX | FOFO |
|---|---|---|
| Price | $1.34 | $5.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 93.3K | 32.0K |
| Earning Date | 05-08-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $181,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $7.44 | $11.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.86 |
| 52 Week High | $3.22 | $68.00 |
| Indicator | ENTX | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 59.97 |
| Support Level | $1.17 | $4.53 |
| Resistance Level | $1.61 | $6.40 |
| Average True Range (ATR) | 0.15 | 0.54 |
| MACD | 0.01 | 0.33 |
| Stochastic Oscillator | 57.38 | 90.72 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.